Annual ROA
-68.26%
+11.18%+14.07%
31 December 2023
Summary:
Apellis Pharmaceuticals annual return on assets is currently -68.26%, with the most recent change of +11.18% (+14.07%) on 31 December 2023. During the last 3 years, it has fallen by -32.36% (-90.14%). APLS annual ROA is now -143.70% below its all-time high of -28.01%, reached on 31 December 2017.APLS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-29.46%
+9.62%+24.62%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly return on assets is currently -29.46%, with the most recent change of +9.62% (+24.62%) on 30 September 2024. Over the past year, it has increased by +40.27% (+57.75%). APLS quarterly ROA is now at all-time high.APLS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.1% | +57.8% |
3 y3 years | -90.1% | +57.4% |
5 y5 years | -9.0% | +57.9% |
APLS ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -90.1% | +15.8% | at high | +69.4% |
5 y | 5 years | -90.1% | +15.8% | at high | +69.4% |
alltime | all time | -143.7% | +44.0% | at high | +87.0% |
Apellis Pharmaceuticals ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -29.46%(-24.6%) |
June 2024 | - | -39.08%(-18.8%) |
Mar 2024 | - | -48.15%(-22.4%) |
Dec 2023 | -68.26%(-14.1%) | -62.02%(-11.1%) |
Sept 2023 | - | -69.73%(-3.8%) |
June 2023 | - | -72.52%(-0.1%) |
Mar 2023 | - | -72.58%(+3.8%) |
Dec 2022 | -79.44%(-2.0%) | -69.93%(-2.3%) |
Sept 2022 | - | -71.59%(-4.6%) |
June 2022 | - | -75.01%(-13.1%) |
Mar 2022 | - | -86.34%(-10.3%) |
Dec 2021 | -81.02%(+125.7%) | -96.23%(+39.3%) |
Sept 2021 | - | -69.08%(+21.5%) |
June 2021 | - | -56.84%(+34.7%) |
Mar 2021 | - | -42.21%(+0.6%) |
Dec 2020 | -35.90%(-54.1%) | -41.96%(-46.9%) |
Sept 2020 | - | -78.97%(+1.3%) |
June 2020 | - | -77.94%(-14.3%) |
Mar 2020 | - | -90.90%(+11.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | -78.28%(+25.0%) | -81.76%(+16.8%) |
Sept 2019 | - | -70.00%(-2.8%) |
June 2019 | - | -72.04%(+18.4%) |
Mar 2019 | - | -60.84%(+4.1%) |
Dec 2018 | -62.64%(+123.6%) | -58.44%(+14.2%) |
Sept 2018 | - | -51.16%(-4.9%) |
June 2018 | - | -53.79%(-11.1%) |
Mar 2018 | - | -60.49%(+2.0%) |
Dec 2017 | -28.01%(-71.7%) | -59.32%(-48.1%) |
Sept 2017 | - | -114.38%(+37.4%) |
June 2017 | - | -83.23%(-0.2%) |
Mar 2017 | - | -83.41%(+65.4%) |
Dec 2016 | -98.87%(-18.9%) | -50.42%(+24.8%) |
Sept 2016 | - | -40.41%(-76.5%) |
Dec 2015 | -121.84%(+61.6%) | -171.98%(-24.1%) |
Sept 2015 | - | -226.53%(+583.3%) |
June 2015 | - | -33.15%(-8.1%) |
Dec 2014 | -75.41%(-1.0%) | -36.06% |
Dec 2013 | -76.19% | - |
FAQ
- What is Apellis Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual ROA year-on-year change?
- What is Apellis Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly ROA year-on-year change?
What is Apellis Pharmaceuticals annual return on assets?
The current annual ROA of APLS is -68.26%
What is the all time high annual ROA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual return on assets is -28.01%
What is Apellis Pharmaceuticals annual ROA year-on-year change?
Over the past year, APLS annual return on assets has changed by +11.18% (+14.07%)
What is Apellis Pharmaceuticals quarterly return on assets?
The current quarterly ROA of APLS is -29.46%
What is the all time high quarterly ROA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly return on assets is -29.46%
What is Apellis Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, APLS quarterly return on assets has changed by +40.27% (+57.75%)